Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Upper Bollinger Band Walk | Strength | 1.14% | |
Outside Day | Range Expansion | 1.14% | |
Upper Bollinger Band Touch | Strength | 1.14% | |
Down 3 Days in a Row | Weakness | 1.14% | |
Gapped Down | Weakness | 1.14% |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-02-01
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.53 |
52 Week Low | 1.12 |
Average Volume | 43,672 |
200-Day Moving Average | 2.202 |
50-Day Moving Average | 1.658 |
20-Day Moving Average | 1.665 |
10-Day Moving Average | 1.767 |
Average True Range | 0.116 |
RSI (14) | 55.16 |
ADX | 20.75 |
+DI | 23.815 |
-DI | 18.099 |
Chandelier Exit (Long, 3 ATRs) | 1.652 |
Chandelier Exit (Short, 3 ATRs) | 1.818 |
Upper Bollinger Bands | 1.917 |
Lower Bollinger Band | 1.412 |
Percent B (%b) | 0.71 |
BandWidth | 30.303 |
MACD Line | 0.045 |
MACD Signal Line | 0.021 |
MACD Histogram | 0.0233 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.890 | ||||
Resistance 3 (R3) | 1.897 | 1.863 | 1.870 | ||
Resistance 2 (R2) | 1.863 | 1.833 | 1.860 | 1.863 | |
Resistance 1 (R1) | 1.817 | 1.814 | 1.840 | 1.810 | 1.857 |
Pivot Point | 1.783 | 1.783 | 1.795 | 1.780 | 1.783 |
Support 1 (S1) | 1.737 | 1.753 | 1.760 | 1.730 | 1.683 |
Support 2 (S2) | 1.703 | 1.734 | 1.700 | 1.677 | |
Support 3 (S3) | 1.657 | 1.703 | 1.670 | ||
Support 4 (S4) | 1.650 |